These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 29745311)

  • 1. Systemic Delays in the Initiation of Antiretroviral Therapy for Clinically Eligible HIV-Infected Patients in Houston, Texas: The Providers' Report Card.
    Mgbere O; Rodriguez-Barradas M; Vigil KJ; McNeese M; Tabassam F; Barahmani N; Wang J; Arafat R; Essien EJ
    J Int Assoc Provid AIDS Care; 2018; 17():2325958218774042. PubMed ID: 29745311
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinician Perspectives on Delaying Initiation of Antiretroviral Therapy for Clinically Eligible HIV-Infected Patients.
    Beer L; Valverde EE; Raiford JL; Weiser J; White BL; Skarbinski J
    J Int Assoc Provid AIDS Care; 2015; 14(3):245-54. PubMed ID: 25394912
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Frequency and Determinants of Preventive Care Counseling by HIV Medical Care Providers during Encounters with Newly Diagnosed and Established HIV-Infected Patients.
    Mgbere O; Rodriguez-Barradas MC; Bell TK; Khuwaja S; Arafat R; Essien EJ; Singh M; Simmons P; Aguilar J
    J Int Assoc Provid AIDS Care; 2016 May; 15(3):215-27. PubMed ID: 25361557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. System and Patient Barriers to Care among People Living with HIV/AIDS in Houston/Harris County, Texas: HIV Medical Care Providers' Perspectives.
    Mgbere O; Khuwaja S; Bell TK; Rodriguez-Barradas MC; Arafat R; Essien EJ; Singh M; Aguilar J; Roland E
    J Int Assoc Provid AIDS Care; 2015; 14(6):505-15. PubMed ID: 24943655
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Delivery of HIV Antiretroviral Therapy Adherence Support Services by HIV Care Providers in the United States, 2013 to 2014.
    Weiser J; Beer L; Brooks JT; Irwin K; West BT; Duke CC; Gremel GW; Skarbinski J
    J Int Assoc Provid AIDS Care; 2017; 16(6):624-631. PubMed ID: 28899259
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factors informing HIV providers' decisions to start antiretroviral therapy for young people living with behaviorally acquired HIV.
    Lee L; Rand CS; Ellen JM; Agwu AL
    J Adolesc Health; 2014 Sep; 55(3):358-65. PubMed ID: 24794054
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sources of clinical information used in HIV care and treatment: Are providers' choices related to their demographic and practice characteristics?
    Mgbere O; Khuwaja S; Vigil KJ; Patel SM; Wang J; Essien EJ
    Health Informatics J; 2019 Dec; 25(4):1572-1587. PubMed ID: 30084724
    [TBL] [Abstract][Full Text] [Related]  

  • 8. On the front line of HIV virological monitoring: barriers and facilitators from a provider perspective in resource-limited settings.
    Rutstein SE; Golin CE; Wheeler SB; Kamwendo D; Hosseinipour MC; Weinberger M; Miller WC; Biddle AK; Soko A; Mkandawire M; Mwenda R; Sarr A; Gupta S; Mataya R
    AIDS Care; 2016; 28(1):1-10. PubMed ID: 26278724
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Socioeconomic factors explain suboptimal adherence to antiretroviral therapy among HIV-infected Australian adults with viral suppression.
    Siefried KJ; Mao L; Kerr S; Cysique LA; Gates TM; McAllister J; Maynard A; de Wit J; Carr A;
    PLoS One; 2017; 12(4):e0174613. PubMed ID: 28369066
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Managing the Personal Side of Health Care among Patients with HIV/AIDS.
    Mgbere O; Khuwaja S; Bell TK; Rodriguez-Barradas MC; Arafat R; Blair JM; Essien EJ
    J Int Assoc Provid AIDS Care; 2017; 16(2):149-160. PubMed ID: 25331218
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adherence to standards of quality HIV/AIDS care and antiretroviral therapy in the West Nile Region of Uganda.
    Burua A; Nuwaha F; Waiswa P
    BMC Health Serv Res; 2014 Nov; 14():521. PubMed ID: 25399661
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dispensation of antiretroviral therapy and methadone maintenance therapy at the same facility in a low-barrier setting linked to optimal adherence to HIV treatment.
    Mohd Salleh NA; Fairbairn N; Nolan S; Barrios R; Shoveller J; Richardson L; Milloy MJ
    HIV Med; 2019 Oct; 20(9):606-614. PubMed ID: 31359615
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Individual factors associated with time to non-adherence to ART pick-up within HIV care and treatment services in three health facilities of Zambézia Province, Mozambique.
    Filimão DBC; Moon TD; Senise JF; Diaz RS; Sidat M; Castelo A
    PLoS One; 2019; 14(3):e0213804. PubMed ID: 30908522
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trends in provider-advised HIV antiretroviral therapy deferral in the United States, 2009-2014.
    Beer L; Weiser J; Luke Shouse R
    AIDS Care; 2019 Jul; 31(7):821-826. PubMed ID: 30466314
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intention to adhere to HIV treatment: a patient-centred predictor of antiretroviral adherence.
    Nelsen A; Gupta S; Trautner BW; Petersen NJ; Garza A; Giordano TP; Naik AD; Rodriguez-Barradas MC
    HIV Med; 2013 Sep; 14(8):472-80. PubMed ID: 23551395
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Physician and patient prediction of adherence to antiretroviral therapy in HIV positive people in Saint-Petersburg, Russia.
    Vetrova MV; Aleksandrova OV; Paschenko AE; Toropov SE; Rassokhin VV; Abyshev RA; Levina OS; Niccolai L; Heimer R
    AIDS Care; 2021 Apr; 33(4):473-477. PubMed ID: 32148065
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factors associated with timely initiation of antiretroviral therapy in two HIV clinics in Lilongwe, Malawi.
    Johnson DC; Feldacker C; Tweya H; Phiri S; Hosseinipour MC
    Int J STD AIDS; 2013 Jan; 24(1):42-9. PubMed ID: 23467293
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Late HIV Diagnosis but Earlier Antiretroviral Treatment Initiation in Northwest Spain: Impact of Current Treatment Guidelines.
    Cid-Silva P; Margusino-Framiñán L; Balboa-Barreiro V; Pernas-Souto B; Mena-De-Cea Á; Martín-Herranz I; Castro-Iglesias Á; Poveda E
    J Int Assoc Provid AIDS Care; 2019; 18():2325958218821940. PubMed ID: 30798655
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Loss to follow-up before and after initiation of antiretroviral therapy in HIV facilities in Lilongwe, Malawi.
    Tweya H; Oboho IK; Gugsa ST; Phiri S; Rambiki E; Banda R; Mwafilaso J; Munthali C; Gupta S; Bateganya M; Maida A
    PLoS One; 2018; 13(1):e0188488. PubMed ID: 29373574
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Barriers to Universal Prescribing of Antiretroviral Therapy by HIV Care Providers in the United States, 2013-2014.
    Weiser J; Brooks JT; Skarbinski J; West BT; Duke CC; Gremel GW; Beer L
    J Acquir Immune Defic Syndr; 2017 Apr; 74(5):479-487. PubMed ID: 28002186
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.